The response to immunotherapy has been linked to human leukocyte antigen (HLA) genotype in certain cancers. A new study examining the interaction between cancer type–specific mutational exposures and the B44 and B27 HLA supertypes finds that patients with mutant peptides complementary to these supertypes receive the most benefit from immune-checkpoint blockade.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schumacher, T. N., Scheper, W. & Kvistborg, P. Annu. Rev. Immunol. 37, 173–200 (2019).
Vinay, D. S. et al. Semin. Cancer Biol. 35, S185–S198 (2015).
Chowell, D. et al. Science 359, 582–587 (2018).
Arora, S. et al. Adv. Ther. 36, 2638–2678 (2019).
Sidney, J., Peters, B., Frahm, N., Brander, C. & Sette, A. BMC Immunol. 9, 1 (2008).
McGranahan, N. et al. Cell 171, 1259–1271.e11 (2017).
Alexandrov, L. B. et al. Nature 500, 415–421 (2013).
Alexandrov, L. B. et al. Science 354, 618–622 (2016).
Cummings, A. L. et al. Nat. Cancer https://doi.org/10.1038/s43018-020-00140-1 (2020).
Negrao, M. V. et al. J. Thorac. Oncol. 14, 1021–1031 (2019).
Capietto, A.-H. et al. J. Exp. Med. 217, e20190179 (2020).
Pham, T. V. et al. Mol. Oncol. 14, 1680–1694 (2020).
Wood, M. A., Weeder, B. R., David, J. K., Nellore, A. & Thompson, R. F. Genome Med. 12, 33 (2020).
Cabrera, T. et al. Hum. Immunol. 64, 941–950 (2003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Castro, A., Carter, H. Mutagenic exposures shape immunotherapy responses. Nat Cancer 1, 1132–1133 (2020). https://doi.org/10.1038/s43018-020-00153-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-020-00153-w